Cocrystal Pharma, INC. (COCP) — DEF 14A Filings
All DEF 14A filings from Cocrystal Pharma, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Cocrystal Pharma DEF 14A: Executive Compensation Details
— May 5, 2025 Risk: medium
Cocrystal Pharma, Inc. filed a DEF 14A on May 5, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes inform -
Cocrystal Pharma, Inc. Announces 2024 Annual Meeting of Stockholders
— May 7, 2024 Risk: low
Cocrystal Pharma, Inc. (COCP) filed a Proxy Statement (DEF 14A) with the SEC on May 7, 2024. Annual Meeting scheduled for June 25, 2024, at 11:00 a.m. ET, held
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX